Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to $268000.0.

  • Agilon Health's Net Cash Flow fell 9928.45% to $268000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $17.9 million, marking a year-over-year increase of 17229.02%. This contributed to the annual value of $79.5 million for FY2024, which is 12021.88% up from last year.
  • According to the latest figures from Q3 2025, Agilon Health's Net Cash Flow is $268000.0, which was down 9928.45% from $32.8 million recorded in Q2 2025.
  • Agilon Health's Net Cash Flow's 5-year high stood at $1.0 billion during Q2 2021, with a 5-year trough of -$352.6 million in Q2 2022.
  • Its 5-year average for Net Cash Flow is $1.7 million, with a median of -$22.6 million in 2023.
  • As far as peak fluctuations go, Agilon Health's Net Cash Flow skyrocketed by 1285800.68% in 2021, and later crashed by 140862.35% in 2025.
  • Over the past 5 years, Agilon Health's Net Cash Flow (Quarter) stood at -$41.1 million in 2021, then tumbled by 38.25% to -$56.8 million in 2022, then decreased by 13.05% to -$64.2 million in 2023, then skyrocketed by 162.4% to $40.1 million in 2024, then crashed by 99.33% to $268000.0 in 2025.
  • Its Net Cash Flow was $268000.0 in Q3 2025, compared to $32.8 million in Q2 2025 and -$55.2 million in Q1 2025.